If you suffered from Xarelto bleeding complications, we may be able to help.Xarelto, which is better for uses like: Blood Clots, DVT and DVT Prophylaxis.Reducing the risk of stroke in people with nonvalvular atrial fibrillation (NVAF).
Bayer is now facing a Xarelto class action lawsuit in Canada, in addition to the ongoing multidistrict litigation in the Eastern District of Louisiana.However, the highly-controversial anticoagulant caused thousands.The FDA approved Xarelto to decrease the risk of deep vein thrombosis, pulmonary embolism and stroke.Rivaroxaban is an oral direct Factor Xa Inhibitor, protecting patients against blood clots by selectively targeting.Portola reversal agent for Xarelto succeeds in late stage trial. By. But there is no approved antidote should the effect of the drugs need to be.
Please provide us any comments, suggestions, or feedback on how we can improve our website.
The number of lawsuits will grow due because more people are taking the drug and have bad reactions.Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug.
According to a February 2016 article published in The New York Times, the U.S. Food and Drug Administration (FDA) is looking into the possibility that a defective blood-testing instrument may have distorted the results of a study, ROCKET AF, involving Xarelto, an anticlotting drug.Xarelto was originally approved by the FDA for use as a blood.
Xarelto Lawsuits Move Toward Trial Dates. The first Xarelto trial date is.
Researchers that oversaw the ROCKET AF study recently conducted an analysis suggesting that the original tests done to measure blood clotting did not significantly compromise safety or efficacy results.If you or a loved one have been affected by a recalled drug or medical device, we can help.